As of 2025-05-14, the Intrinsic Value of ST Pharm Co Ltd (237690.KQ) is 80,416.87 KRW. This 237690.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 73,600.00 KRW, the upside of ST Pharm Co Ltd is 9.30%.
The range of the Intrinsic Value is 44,160.69 - 230,923.11 KRW
Based on its market price of 73,600.00 KRW and our intrinsic valuation, ST Pharm Co Ltd (237690.KQ) is undervalued by 9.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (107,794.06) - (31,786.49) | (46,603.37) | -163.3% |
| DCF (Growth 10y) | 44,160.69 - 230,923.11 | 80,416.87 | 9.3% |
| DCF (EBITDA 5y) | 95,826.78 - 176,114.28 | 121,546.59 | 65.1% |
| DCF (EBITDA 10y) | 190,148.78 - 365,711.10 | 247,320.92 | 236.0% |
| Fair Value | 43,066.75 - 43,066.75 | 43,066.75 | -41.49% |
| P/E | 40,000.28 - 69,872.32 | 50,370.76 | -31.6% |
| EV/EBITDA | 27,331.41 - 70,799.77 | 49,895.77 | -32.2% |
| EPV | (7,845.01) - (9,284.32) | (8,564.67) | -111.6% |
| DDM - Stable | 22,817.58 - 107,935.92 | 65,376.67 | -11.2% |
| DDM - Multi | 101,288.39 - 366,629.21 | 158,058.06 | 114.8% |
| Market Cap (mil) | 1,483,040.00 |
| Beta | 0.53 |
| Outstanding shares (mil) | 20.15 |
| Enterprise Value (mil) | 1,537,776.80 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.36% |
| Cost of Debt | 4.25% |
| WACC | 7.06% |